
CSO Simmaron Research ; MIDD member, @RedefiningMECFS; CoFounder/Sci. Director of SIMMPHARM: Professor (adj) @UWM; Neurobio; ME/CFS; Drug design and development
Milwaukee, WI
Joined October 2019
- Tweets169
- Following25
- Followers677
- Likes187
Roy lab retweeted
Take a scroll break and listen to the next step in our Rapamycin treatment trial for #MECFS and #LongCovid. Dr. Gunnar Gottschalk provides a look forward as we start gearing up for a double blind placebo trial. #GivingTuesday
Roy lab retweeted
Appreciate Simmaron highlighting this work. There’s a real need for more rigorous research in ME/CFS, POTS, and Long COVID, and we’re proud to help build the evidence base around Rapamycin.
Roy lab retweeted
Rapamycin may tie these three converging threads together in ME/CFS. @RedefiningMECFS @UWM @SpringerNature @ggottschalkPhD
The link of our newest article
link.springer.com/article/10…
Roy lab retweeted
Watch! Dr. Avik Roy & Dr. Gunnar Gottschalk of @RedefiningMECFS share how six years of work on the molecular mechanisms of #MECFS has led to one of the only ongoing clinical trials specifically designed around a defined biological target.
youtu.be/OMmjcTKxivU
#MEAwarenessHour
Roy lab retweeted
The #UWM community extends its heartfelt sympathies and condolences to the @MarquetteU lacrosse team and the entire Marquette community for the tragic loss of its two student-athletes. We are keeping you in our thoughts.
Roy lab retweeted
New Pre-pint from our team @RedefiningMECFS . Genetic depletion of early autophagy protein ATG13 impairs mitochondrial energy metabolism, increases oxidative stress, and preferentially induces the pro inflammatory M1 phenotype of macrophages. researchsquare.com/article/r…
Roy lab retweeted
🚨 Big news! Simmaron Research wins our latest Solve #MECFS Catalyst Award! We’re proud to provide funding for the Low-Dose Rapamycin trial. Congrats to @ggottschalkPhD @AvikRoy74969264 & the whole @RedefiningMECFS team!
💡 Learn more:ow.ly/WSsW50WavSb

ALT Pictured are two researchers from Simmaron Research: Dr. C. Gunnar Gottschalk (blonde hair, blue shirt, blue pants) and Dr. Avik Roy (black hair, blue jacket, grey pants). The graphic depicts a blue three-pronged shape with an orange and yellow flame emerging from the top prong. The text reads "Solve ME/CFS Catalyst Award Winner -- "Low Dose Rapamycin in ME/CFS, Long-COVID, and Other Infection Associated Chronic Conditions.”
Roy lab retweeted
We are excited to share some early results of our low dose rapamycin project in #ME, in its pre-print version here. TY to @ggottschalkPhD, @AvikRoy74969264 & Dr. David Kaufman for leading it, to all our collaborators & to study patients! #MECFS 1/9
researchsquare.com/article/r…
Roy lab retweeted
We @RedefiningMECFS and @AvikRoy74969264 are excited to share some early results of our low dose rapamycin project in its pre-print version here. Thanks to all the patients for participating!
researchsquare.com/article/r…
Roy lab retweeted
An Explosion of ME/CFS in the US + The Real Difference RECOVER May Make In Long COVID healthrising.org/blog/2025/0… #MECFS #longCOVID
Roy lab retweeted
Congrats to the entire team @RedefiningMECFS and @AvikRoy74969264 on this breakthrough paper describing a disease-relevant model of PEM
link.springer.com/content/pd…
Here, we show that chronic mTOR activation disrupts autophagy function, leading to PEM and the production of IL-6 and RANTES via STAT3 phosphorylation!
Roy lab retweeted
Exciting news! We have formed a strategic partnership with @AgelessRx, a leader in decentralized clinical trial execution, to expand our #rapamycin treatment trial for #ME and #LongCovid in the new year. Read more: simmaronresearch.com/blog/si… 1/2
Roy lab retweeted
Only 2 weeks until #GivingTuesday! This marks 9 months of our #rapamycin trial in #MECFS and #LongCovid. Phase 1 is on its way to results on symptoms and biomarkers. Donate now to this groundbreaking work! #ME #POTS #PEM bit.ly/Simmaron
Roy lab retweeted
Replying to @DrDavidACox @PutrinoLab
There's also another fascinating trial being led by @AvikRoy74969264 at @RedefiningMECFS of low-dose rapamycin in people with ME/CFS to see whether it can improve mitochondrial function and quality of life by stimulating cellular recycling and repair.
Roy lab retweeted
We're proud to be part of Milwaukee Institute for Drug Discovery & grateful to partner with them on the science of our #rapamycin trial. #ME #LongCovid patients need this kind of collaboration to develop treatments! Donate to this work! #MIDD @UMW #MECFS bit.ly/Simmaron
Roy lab retweeted
We continue to make good progress on the Rapamycin trial. I’m so thankful to the participants. You can’t do this kind of research without their guidance and participation. The quote below is one of many. Not everyone will respond. This isn’t my first rodeo. Our goal is biomarker directed clinical trials—like we are doing now. Understanding responders to therapy will help the field of #MECFS and #LongCovid. Thanks to our collaborators @GrachStephanie @CornellMECFS @BatemanHorne David Kaufman MD, Bela Chheda MD, Dan Peterson MD and Jon Berner MD.
“I am a responder to the rapamycin. I am not sure if the details are of any interest or maybe helpful to the research but I’ll include a few. The next day after taking my first dose, I noticed immediately I was able to retain twice the amount of water I usually do (I have a schedule of water and salt intake for POTS). For the next four days I incrementally felt this sensation of blood returning to my brain, kind of like when your arm falls asleep and it feels tingly when it “wakes up”.
I was 100% bedbound before starting and now I can sit at my desk for 4 hours. I will be attempting more movement here shortly. The RELIEF in my brain is astronomical. My anhedonia and dissociation has hugely improved, I can feel some emotions again from my memories.”
Thanks for your support of @RedefiningMECFS
Roy lab retweeted
Please check out Simmaron's newest publication here! Thank you to all of the patients and our supporters!
doi.org/10.1177/117957352412…
“Dysregulation of tetrahydrobiopterin metabolism in myalgic encephalomyelitis/chronic fatigue syndrome by pentose phosphate pathway”
@RedefiningMECFS @AvikRoy74969264 @PlzSolveCFS @NINDSdirector @NIH_NINDS
Roy lab retweeted
Who out there knew that inks used for permanent tattoos contain heavy metals, including mercury (red inks)? Before you got a tattoo? Do you really want this exposure? On top of microplastics, POPs and various xenobiotics? Here’s an easy (but worrying) read from Sci Am:
scientificamerican.com/artic…
Tattoos as a risk factor for malignant lymphoma thelancet.com/journals/eclin…
Roy lab retweeted
Huge congrats to Molly Drosen and Amy Reyes for taking 1st and 2nd place presenting their posters describing key mechanisms underlying ME/CFS at the UWM annual chemistry symposium! Great mentorship from Avik Roy!! @UWM @RedefiningMECFS @AvikRoy74969264
Roy lab retweeted
Rapamycin pilot study. Happening now in the US. It’s cheap (off patent and available). We hypothesize chronic mTOR activation drives autophagy disruption.
pubmed.ncbi.nlm.nih.gov/3548…
Check out simmaron.com for details.














